【摘要】：背景： 目前隨著PCI治療冠心病數(shù)量的增多，冠狀動脈穿孔（CAP）的發(fā)生也隨之增多，CAP作為一種少見但嚴重的并發(fā)癥也越來越受到臨床介入醫(yī)生的重視。CAP受到很多因素的影響，但目前國內研究多為散發(fā)病例報道，國外研究結果相互矛盾，治療手段缺乏統(tǒng)一標準。本研究通過回顧性分析方法，以期為冠狀動脈穿孔的防治積累更多的理論支持。 目的： 探討PCI過程中冠狀動脈穿孔的發(fā)病率、危險因素和治療策略。 方法： 本研究回顧了吉林大學白求恩第一醫(yī)院心血管中心2011年1月到2015年1月住院接受PCI的11853例患者，其中男8356例，女3497例。發(fā)現(xiàn)冠狀動脈穿孔病人41例，其中男25例，女16例。余下11812例中隨機抽取105例，作為正常對照組，對其進行臨床回顧性分析，包括病人基本臨床資料、介入手術操作及治療策略相關資料。 結果： ①總發(fā)生率為0.35%，，死亡率4.88%。②單因素分析結果顯示：穿孔組與未穿孔組在年齡（P=0.007）、B2+C類病變（P＜0.001）、重度鈣化病變（P=0.005）、慢性完全閉塞病變（P＜0.001）、小血管病變（P=0.011）、多支血管病變（P=0.003）、前降支病變（P=0.023）間差異具有統(tǒng)計學意義（P＜0.05）。多元Logistic回歸分析顯示：年齡增加（OR1.05；95%CI1.002-1.101）、重度鈣化病變（OR3.08；95%CI1.252-7.558）、慢性完全閉塞病變（OR2.80；95%CI1.083-7.225）、前降支病變（OR2.56；95%CI1.098-5.946）是冠狀動脈穿孔的獨立危險影響因素。③冠狀動脈穿孔多與球囊（43.90%）和導絲(41.46%)操作有關。④球囊低壓擴張、栓塞、覆膜支架植入、心包穿刺引流、血液回輸和緊急外科手術是冠狀動脈穿孔的有效治療方法。 結論： ①冠狀動脈穿孔作為PCI并發(fā)癥發(fā)生率低。②穿孔組與未穿孔對照組在年齡、B2+C類病變、重度鈣化病變、慢性完全閉塞病變、小血管病變、多支血管病變、前降支病變組間差異具有統(tǒng)計學意義。③年齡增加、重度鈣化病變、慢性完全閉塞病變、前降支病變是冠狀動脈穿孔的獨立危險因素。④經(jīng)球囊低壓擴張、栓塞、覆膜支架植入、心包引流、血液回輸?shù)戎委熀笃漕A后良好。
[Abstract]:Background:
At present, with the increase of the number of coronary heart disease (PCI), the incidence of coronary artery perforation (CAP) is also increasing. As a rare but serious complication, CAP is becoming more and more seriously affected by the attention of clinical interventional doctors. However, the domestic research is mostly reported in scattered cases, and the results of foreign research are contradictory and treatment. There is a lack of uniform standard. This study provides a more theoretical support for the prevention and treatment of coronary artery perforation through retrospective analysis.
Objective:
Objective to investigate the incidence, risk factors and treatment strategies of coronary artery perforation during PCI.
Method:
This study reviewed 11853 patients who were hospitalized in the cardiovascular center of Bethune First Hospital of Jilin University from January 2011 to January 2015, including 8356 males and 3497 females. 41 cases of coronary artery perforation were found in 25 men and 16 women. 105 of the remaining 11812 cases were randomly selected as the normal control group, and the clinical retrospective was reviewed. Analysis included basic clinical data, interventional operation and treatment strategy.
Result:
(1) the total incidence was 0.35%, and the single factor analysis of mortality 4.88%. showed that the difference in age (P=0.007), B2+C type lesion (P < 0.001), severe calcification (P=0.005), chronic complete occlusion (P < 0.001), small vascular disease (P=0.011), multiple vessel lesion (P=0.003), and anterior descending branch (P=0.023) in the perforation group and the non perforation group were in general. Study significance (P < 0.05). Multivariate Logistic regression analysis showed that age increased (OR1.05; 95%CI1.002-1.101), severe calcification (OR3.08; 95%CI1.252-7.558), chronic complete occlusion (OR2.80; 95%CI1.083-7.225), and anterior descending lesion (OR2.56; 95% CI1.098-5.946) were independent risk factors for coronary artery perforation. Multiple pulse perforation is related to the operation of balloon (43.90%) and guide wire (41.46%). 4. Balloon dilatation, embolism, stent implantation, pericardial drainage, blood transfusion and emergency surgery are effective methods for the treatment of coronary artery perforation.
Conclusion:
(1) the incidence of coronary artery perforation as a PCI complication was low. (2) the differences in age, B2+C, severe calcification, chronic complete occlusion, small vascular lesions, multiple vessel lesions, and anterior descending lesions were statistically significant in the group of perforation and non perforation. Anterior descending lesion is an independent risk factor for coronary artery perforation. (4) the prognosis is good after balloon dilatation, embolization, stent implantation, pericardial drainage and blood transfusion.
【學位授予單位】：吉林大學
【學位級別】：碩士
【學位授予年份】：2015
【分類號】：R541.4

【相似文獻】

相關期刊論文 前10條

1 金少峰;何勁松;;成功處理經(jīng)皮冠狀動脈介入治療術中冠狀動脈穿孔一例[J];實用心腦肺血管病雜志;2013年02期

2 喬樹賓,高潤霖,陳紀林,左魯寧,楊躍進,秦學文,姚民,劉海波,徐波,吳永健,姚康寶;經(jīng)皮冠狀動脈腔內成形術并發(fā)冠狀動脈穿孔[J];中國循環(huán)雜志;2000年03期

3 劉建平,王彬堯,鄭道聲,林延齡,辜天海;冠狀動脈介入治療并發(fā)冠狀動脈穿孔的處理[J];臨床心血管病雜志;2003年01期

4 王樂豐,徐立,楊新春,王紅石,葛永貴,鄒陽春,佟子川,李惟銘,孫曉裴,閻玉虎;經(jīng)皮冠狀動脈介入治療并發(fā)冠狀動脈穿孔的處理[J];上海醫(yī)學;2003年03期

5 沈東,黃黨生,羅北捷,張麗偉,夏云峰,張許文,張春紅,白靜;冠狀動脈介入治療并發(fā)冠狀動脈穿孔5例報告[J];解放軍醫(yī)學雜志;2004年05期

6 沈東;黃黨生;張麗偉;夏云峰;張許文;張春紅;白靜;羅北捷;;經(jīng)皮冠狀動脈介入治療并發(fā)冠狀動脈穿孔及心包填塞的處理[J];中國急救醫(yī)學;2005年12期

7 高展;楊躍進;陳紀林;喬樹賓;李建軍;徐波;秦學文;姚民;劉海波;吳永建;袁晉青;陳玨;尤士杰;高潤霖;;經(jīng)皮冠狀動脈介入治療術中冠狀動脈穿孔32例臨床分析[J];中國實用內科雜志;2007年15期

8 李公信;劉映峰;王艷麗;李志梁;葉文勝;;冠狀動脈介入治療并發(fā)冠狀動脈穿孔的臨床分析[J];南方醫(yī)科大學學報;2008年11期

9 王惠琴;;明膠海綿栓塞成功治療冠狀動脈穿孔1例[J];中華老年多器官疾病雜志;2010年04期

10 王成全;吳海霞;馮雪影;白焱;張春芳;;經(jīng)導管冠狀動脈介入治療引起冠狀動脈穿孔10例臨床分析[J];中國實用醫(yī)藥;2010年32期

相關會議論文 前3條

1 梁峰;曹樹軍;王立中;王金波;胡大一;吳明英;李田昌;湯楚中;王吉云;盧長林;;外科手術治療冠狀動脈穿孔遲發(fā)心包壓塞一例[A];中華醫(yī)學會第11次心血管病學術會議論文摘要集[C];2009年

2 夏勇;錢文浩;潘德鋒;;前降支經(jīng)皮冠狀動脈介入治療中并發(fā)Ⅱ型冠狀動脈穿孔一例[A];中華醫(yī)學會心血管病學分會第八次全國心血管病學術會議匯編[C];2006年

3 劉莉;高陽;李彤;李占全;張明;袁龍;金元哲;;冠心病介入治療伴冠狀動脈穿孔治療及臨床預后[A];中華醫(yī)學會心血管病分會第八次全國心血管病學術會議匯編[C];2004年

相關碩士學位論文 前1條

1 黃爍;PCI冠狀動脈穿孔風險因素及治療策略[D];吉林大學;2015年

本文編號：2120523